You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 156 No. 6, 25 MARCH 1996 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  CLINICAL OBSERVATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (39)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Erythromycin-Induced Clozapine Toxic Reaction

Louise Glassner Cohen, PharmD; Shelley Chesley, MD; Linda Eugenio, PharmD; James G. Flood, PhD; Judith Fisch, MD; Donald C. Goff, MD

Arch Intern Med. 1996;156(6):675-677.


Abstract



Clozapine, used in the treatment of patients with schizophrenia resistant to other neuroleptic medication, is metabolized by the hepatic microsomal system to demethyl-clozapine and clozapine-N-oxide. Changes in clozapine serum concentrations have been documented after initiation of therapy with medications known to induce or inhibit liver microsomal enzymes. These interactions are of clinical importance when diminished efficacy or increased toxic effects of clozapine therapy occur. A 34-year-old schizophrenic man had increased clozapine serum concentrations, leukocytosis, and adverse effects as a result of concomitant erythromycin therapy given for a suspected lower respiratory tract infection. Symptoms included somnolence, difficulty in coordination and ambulation, slurred speech, disorientation, and incontinence. The symptoms resolved after treatment with clozapine and erythromycin were discontinued, and treatment with clozapine was gradually resumed.

(Arch Intern Med. 1996;156:675-677)



Author Affiliations



From the Department of Pharmacy Practice, Bouve College of Pharmacy, Northeastern University, Boston, Mass (Dr Cohen); Departments of Pharmacy (Dr Cohen), Clinical Chemistry (Dr Flood), and Medicine (Dr Fisch) and Psychiatry Service (Drs Chesley and Goff), Massachusetts General Hospital, Boston; and Division of Pharmacy Practice, Massachusetts College of Pharmacy, and Department of Pharmacy, Lahey Clinic, Burlington, Mass (Dr Eugenio).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Interindividual Variation in Relative CYP1A2/3A4 Phenotype Influences Susceptibility of Clozapine Oxidation to Cytochrome P450-Specific Inhibition in Human Hepatic Microsomes
Zhang et al.
Drug Metab. Dispos. 2008;36:2547-2555.
ABSTRACT | FULL TEXT  

Fatal Interaction between Clarithromycin and Colchicine in Patients with Renal Insufficiency: A Retrospective Study
Hung et al.
Clinical Infectious Diseases 2005;41:291-300.
ABSTRACT | FULL TEXT  

Metabolism of Clozapine by cDNA-Expressed Human Cytochrome P450 Enzymes
Linnet and Olesen
Drug Metab. Dispos. 1997;25:1379-1382.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.